Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. BRKRP

Market Cap: $8.02B

BC

Bruker Corporation

BRKRP
NASDAQUSD
Purchase BRKRP
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin46.69%
EBITDA Margin7.08%
EBIT Margin0.50%
Pre-tax Margin-0.80%
Net Profit Margin-2.03%
Earnings Yield-0.88%
Valuation Multiples
Price / Book3.39
Price / Sales2.32
Price / Earnings-76.44
PEG0.87
Forward PEG-5.98
EV / Sales2.82
EV / EBITDA39.82
EV / Operating Cash Flow51.81
EV / Free Cash Flow105.05
Price / Free Cash Flow86.62
Price / Operating Cash Flow42.71
Cash Flow & Capital
Free Cash Flow / Share$0.62
Operating Cash Flow / Share$1.25
Free Cash Flow Yield1.15%
Capex / Revenue2.76%
Capex / Operating Cash Flow50.68%
Capex / Depreciation0.42
Stock Compensation / Revenue0.00%
Dividend Payout Ratio-76.83%
Dividend Yield0.37%
Liquidity & Leverage
Current Ratio1.85
Quick Ratio0.92
Cash Ratio0.15
Debt / Assets0.32
Debt / Capital0.44
Debt / Equity0.80
Long-Term Debt / Capital0.43
Debt / Market Cap23.55%
Net Debt / EBITDA6.99
Solvency Ratio0.04
Financial Leverage2.52
Efficiency & Working Capital
Asset Turnover0.58
Fixed Asset Turnover4.90
Inventory Turnover1.67
Receivables Turnover4.00
Payables Turnover9.32
Days Sales Outstanding91.3
Days Inventory Outstanding219.13
Days Payables Outstanding39.17
Operating Cycle310.44
Cash Conversion Cycle271.27
Working Capital Turnover3.96
Returns & Quality
Return on Equity-2.92%
Return on Assets-1.18%
Return on Invested Capital2.56%
ROCE2.61%
Return on Tangible Assets-1.54%
Operating Return on Assets2.08%
Income Quality-2.89
Tax Burden2.53
Interest Burden-1.60
Balance Sheet & Intrinsic Metrics
Enterprise Value$9.86B
Invested Capital$3.16B
Working Capital$1.02B
Tangible Asset Value$989.2M
Net Current Asset Value$-1.41B
Graham Net-Net-$14.67
Book Value / Share$15.89
Tangible Book Value / Share$6.5
Cash / Share$1.21
Financial Health Scores
Piotroski Score5
Altman Z-Score2.40
Revenue$3.5B
EBIT$27.1M
Market Cap$9.79B
Working Capital$1.02B
Retained Earnings$0
Total Assets$6.05B
Total Liabilities$3.65B